Skip to main content

Find Clinical Trials

Home
Conditions
Resectable Oral and Oropharyngeal Squamous Cell Carcinoma

Clinical trial condition

Resectable Oral and Oropharyngeal Squamous Cell Carcinoma

Explore clinical trials studying Resectable Oral and Oropharyngeal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Resectable Oral and Oropharyngeal Squamous Cell Carcinoma trial results

Not Yet Recruiting

Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

NCT07079410

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
Locations: Zhongshan Hospital Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma

NCT06728618

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
Locations: Zhongshan Hospital Fudan University Shanghai, Shanghai Municipality, China

View Trial Details